{"name":"Cyclacel Pharmaceuticals, Inc.","slug":"cyclacel-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNVDhxWWlkeVB5aW11ZU5HU2RRSkZuX09kdEpLSWFvU2JLZ2lDVmtDMU9MbjRjVlplNl90T19CdUpSaHNZNEhIQnd2TndyWUF3aDdZXzQyMjZxLWdyOXgzejZwOTlhamZPVVdwN3pXTmczVkNLLTVKdmR3b1dyd2c5WkpoZ25XQWlHOE1XU0U2Y3hlcEp4eloxZEF5VTBmWkFicC1MbnVIeFlfTExrUTlCeVJldERxVDMxX0NVdWlMelZtQTNSbWN6VDVR?oc=5","date":"2026-03-15","type":"trial","source":"AD HOC NEWS","summary":"Cyclacel Pharmaceuticals Stock (ISIN: US23254S1069) Faces Cash Crunch Amid Pivotal Trial Hopes - AD HOC NEWS","headline":"Cyclacel Pharmaceuticals Stock (ISIN: US23254S1069) Faces Cash Crunch Amid Pivotal Trial Hopes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE5sbkQ5QVNCY2w2c1V4MG9zLVdqOGN1UVNQQjhNakFmamlsWGVlRjQtTGs3YXJabkt1am8xYkhPaDg5VU9vbmdBLUFHN3dFdVhYb3ZqVXBiRQ?oc=5","date":"2026-03-13","type":"pipeline","source":"Stock Titan","summary":"CYCC SEC Filings - Cyclacel Pharma 10-K, 10-Q, 8-K Forms - Stock Titan","headline":"CYCC SEC Filings - Cyclacel Pharma 10-K, 10-Q, 8-K Forms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9kZzVrZFR0NEhiMzk0V2I3dzNNdDFmSG1XVlB6bmh5Z0RzN1FCblFGSDhQT2JYNm9BWEhvdHpOOFljcFFKT0k4WW5wT1k2bmhqQjdnTUFDcE9lNDN3Q3ZZ?oc=5","date":"2025-09-11","type":"pipeline","source":"ChartMill","summary":"CYCC Stock Price, Quote & Chart | CYCLACEL PHARMACEUTICALS INC (NASDAQ:CYCC) - ChartMill","headline":"CYCC Stock Price, Quote & Chart | CYCLACEL PHARMACEUTICALS INC (NASDAQ:CYCC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOT1ZNcXhBM3hQVDVlQXY3M0NzQ2VqVTVmMUF2ck9qSU9lMlBpWU1ObERmMUwyUG9oeDRjUGxOSWdSVkJlOGxPd1M4X2FWblI5REcwNHFxY2Q5T28tRkgzQ250Qnd0eU5xQWZlUzlEVEl1ZmpVM3BnbndEakFUUmM1bmc1LXBLVlFhZUJZRWU1VUNobXRmUkNiZTNXa0ZSLTJZbXRZN3l4bjBySUhnR05WTUV6MHlJZER3SkhHSzlodzRQSUNlZ2FYYVhSNHc?oc=5","date":"2025-09-05","type":"regulatory","source":"Investing.com","summary":"Cyclacel Pharmaceuticals shareholders approve share issuance and name change - Investing.com","headline":"Cyclacel Pharmaceuticals shareholders approve share issuance and name change","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4AJBVV95cUxQelVqUUtVQkdDRUx4NnJaSmJxUHB1cDhtclQ3UEdtRTZlTzJTYnVOV1hYdnYwVDZOclowT3cxUFIxVEt2MURCYnJrVGxMeERLc0dXdmN0MHV6cWNXUFh3RTRDOFJDd0N3SW9ST0p6dWluLVlUc3FZV2kxNVNlMExCTWp3YWFxZURWcXZ3Q3dFeUszd25RUkt1VVZFTmp2eTVNUXdub3JJM2dxd2Zzd0ZTOEpoNF9xbWNrRWNRMGZ1X0lsd2w4YmtYbEFzanQxTXBsUm51a2ctZXlzc3VTZ1lic3NzX0UyeURJQUlRMUY1SWl2MEdrYzl4N1FNSkVpUTMxd3VJeHhBLWoyeXZfVUhzQThQYV9qNUdteXZSVkpfRnM4REwzMXFxdThQSWlKY3p3RGdqdnptRjFSNDNiZURFV2ZlYVdhWXN4d1hja1VrQkxJVEJ0M1F5M3RVMm9zVEIz?oc=5","date":"2025-05-06","type":"pipeline","source":"GlobeNewswire","summary":"CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE - GlobeNewswire","headline":"CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9lenJkV0dtRFVRaUNxblByV1drSi00Vnl5NUoyZ2pVRHBqLV92bUk5NXIwTGJFYU5tV2lib3llcUxKWEVNY0tWSDg5M2IxQXRVVVE0?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"CYCC Stock Price, News & Analysis - Stock Titan","headline":"CYCC Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQTGlmNXYzTm1zV1BSTTg0c3Bkd2xGT2lMSkltaDJuNGhpdHdiM2JtT2ZvM3lmYXhVX0pVRkp4bUQ0OC1uT2xZZkY5aWoxWmt2Q1hHcjNPMmdwMXpkZGUzRVJpaUM0V0Fqd3U0dkNBcjZmb1dMVjZnZUlmR1lHRnczRElFa1MyaVpBNE9JQzFBRW9SNURocE5xMUNzWElRbUpfNzRTZjVaTlRhUHl3eFdTXzhKTXo?oc=5","date":"2025-04-02","type":"pipeline","source":"Fierce Biotech","summary":"Cyclacel Pharmaceuticals sheds clinical cancer asset in effort to stop cash spiral - Fierce Biotech","headline":"Cyclacel Pharmaceuticals sheds clinical cancer asset in effort to stop cash spiral","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOU1pXX2loSEV3V2Z5ZmVVVkxfendDNlZaSGdWRDNUb0wxM0xPVTA2eXROOEpHcEF4MkxDckNPeWFwNi1kdDZGa3I0N25TMDRxLWExVU9NZHJVbllGMEZIZ2Z6SlhMUlpKclV2M3U0MHNTRVBuLVpJa2VzTzFnT19iMHdmQQ?oc=5","date":"2025-03-04","type":"pipeline","source":"ARC Group","summary":"Share Purchase and Change of Control of Cyclacel - ARC Group","headline":"Share Purchase and Change of Control of Cyclacel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOY180bzQyTm1LWUZQR3VqdUVGbXFVN2ZFMzBvWl9XMzc1REJSalpSWkFUNWVSZkxJcVVtdzVfMllPN2Y2Wlprb2hMTkJHbS16QkQ0eFllZjZHYU9TTnh0WTdnSmdwMEVGNFBvUm5tMjRVNm0wMy0taXlHZmg3dTY4SUc3UnVEZk56bWczag?oc=5","date":"2024-10-22","type":"trial","source":"timothysykes.com","summary":"Cyclacel Pharmaceuticals: Breaking Down Recent Developments in Cancer Therapy Trials - timothysykes.com","headline":"Cyclacel Pharmaceuticals: Breaking Down Recent Developments in Cancer Therapy Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPdlJmVkVycWZfeDNOUmhNUzEzOFlGOE1CNWVaRkdSODlkcHVHRnN0OEdYVVBWb01RLXJtdGQtTm5VOHZOX1VmamM4UmhUak14TC1nV0wxODdBYTZXYUx3bzZlS1VKc1UybzR4U3FLWWZ6cGktRjdrTXNsa2VuMENyZEhXUnJCTzcwRDA4Z3pNYw?oc=5","date":"2024-04-25","type":"pipeline","source":"Yahoo Finance","summary":"Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future - Yahoo Finance","headline":"Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQamtWNVRHdVRLeHJvUHFNSTd5RklVU0ljLXg0a1lWUU5OSkJSeTdpQzBvRExjbUktRThTMno1cTBtNXV3LTI5NTc5TlhQOUc2UzdGd0hXcW5oQnFhWVloTExQVjdENGFCLTdqcjU2X0gySmVDWFlLYWNpNXE1MGdJSHhIeHl1dHV6ZDQ2SmRfWE50Z0xqbE9PQTBQeTVBaTZlRERzSnI1Vl9SX0cwYWxCVGVadWtfUk0?oc=5","date":"2024-01-30","type":"pipeline","source":"citybiz","summary":"Cyclacel Pharmaceuticals Appoints Brian Schwartz, M.D. as Chief Medical Officer - citybiz","headline":"Cyclacel Pharmaceuticals Appoints Brian Schwartz, M.D. as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPR1hSZTdiVTY3ZUpNdldZLTJxWno0SEFxNFNlcEtJcEdOMWlPTmlWVVV2MzhfSmhhcmx1cUYwaXlqOU1zeVh6dmJiUlFGb3RiT0F6cWtTM2tiT3V1MEdwWk5zNjRaQUwtVFQxaDU0eDBqNHZnSVpYb19HdlpMbVVZOVlYdURKamtUV3NGNGd4VkdyRmZNdDJMYkZEbGlQNzktTVNhRHR1MlpMZk9VQ0RLaFZMVzVpUzR6dEpOaWFHWlBPYU9CR1ZySEJZZ3M?oc=5","date":"2023-04-27","type":"pipeline","source":"docwirenews.com","summary":"Spiro Rombotis, CEO of Cyclacel Pharmaceuticals, on Innovative Targeted Therapies for Advanced - docwirenews.com","headline":"Spiro Rombotis, CEO of Cyclacel Pharmaceuticals, on Innovative Targeted Therapies for Advanced","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}